🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators believe that administering Dupilumab during the pre- and ...
Status
Completed
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Start Date
2021-05-25
Trial ID
NCT04596189
Treatments Being Tested
Study D5553C00002 is a multicenter, randomized, double-blind, placebo-contr...
Status
Completed
Location
Research Site
Start Date
2014-09-06
Trial ID
NCT02229383
Treatments Being Tested
This study is a Phase IIa, randomized, multi-site, two-arm, double-blinded ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-27
Trial ID
NCT02076178
Treatments Being Tested
This international, multi-centre, double-blind vaccine study is a three-arm...
Status
Completed
Location
MRC/UVRI and LSHTM Uganda Research Unit
Start Date
2020-12-15
Trial ID
NCT04066881
Treatments Being Tested
This is a single-center, randomized, double-blind, placebo-controlled, dose...
Status
Recruiting
Location
The second affiliated hospital of Nanjing Medical University
Start Date
2023-07-24
Trial ID
NCT06106685
Treatments Being Tested
This is a multicenter, double blind, placebo controlled, multiple dose stud...
Status
Terminated
Location
NW FL Clinical Research Group, LLC
Start Date
2018-07-27
Trial ID
NCT03400852
The primary objectives of the study are: * To describe the safety profile ...
Status
Terminated
Location
Investigational Site Number :8400003
Start Date
2021-03-12
Trial ID
NCT04798027
Danirixin (DNX) is a novel, selective, and reversible antagonist of the C-X...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-01-19
Trial ID
NCT02927431
Treatments Being Tested
This study is being conducted to evaluate the efficacy and safety of ASA co...
Status
Completed
Location
Central Research Associates, Inc.
Start Date
2023-09-06
Trial ID
NCT06000410
Treatments Being Tested